GWM
AXDX icon

Greenwich Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History

Greenwich Wealth Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,080
Closed -$9K – 229
2023
Q2 		$9K Hold
1,080
– – ﹤0.01% 236
2023
Q1 		$8K Hold
1,080
– – ﹤0.01% 236
2022
Q4 		$8K Buy
+1,080
New +$11.8K ﹤0.01% 236

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CI
Chartist Inc Seal Beach, California $160M AUM 15.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCI Wealth Advisors
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Greenwich Wealth Management's AXDX Position: Q3 2023 in Review

Greenwich Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 1,080 shares — an estimated $9K sold.

Greenwich Wealth Management first reported a position in AXDX in Q4 2022 and held it in 3 quarters. The position peaked at $9K in Q2 2023. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.

  • Greenwich Wealth Management reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Greenwich Wealth Management sold 1,080 Accelerate Diagnostics shares in Q3 2023, an estimated $9K.
  • Greenwich Wealth Management first reported a position in Accelerate Diagnostics in Q4 2022 and held it in 3 quarters.
  • Greenwich Wealth Management's Accelerate Diagnostics position peaked at $9K in Q2 2023.
  • 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.

Based on Greenwich Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.